NCT05237349 2024-01-05
Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
Clinical Trials
7 trialsNCT05241132 2022-02-15
Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary
Shanghai Changzheng Hospital
Phase 2 Unknown
NCT01665417 2017-02-08
Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT02103257 2015-04-29
Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT02283424 2014-11-05
Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation
Chinese PLA General Hospital
Phase 4 Unknown
NCT00894153 2012-04-09
p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage
Shenzhen SiBiono GeneTech Co.,Ltd
Phase 4 Unknown
NCT00902083 2012-04-09
rAd-p53
Shenzhen SiBiono GeneTech Co.,Ltd
Phase 4 Unknown